Picture EBD Group BIO Europe 2016 BEU Cologne November 600x60px

News > All

Total search results: 10474 | Ordered by Date (descending)
1 2 3 ... 103 104 105  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
AC Immune S.A.. (9/23/16). "Press Release: AC Immune Announces Pricing of Upsized Initial Public Offering". Lausanne. 2016-09-23
AC Immune S.A.. (9/23/16). "Press Release: Switzerland’s AC Immune Opens for Trading on Nasdaq". Lausanne. 2016-09-23
BRAIN AG. (9/23/16). "Press Release: Changes in the BRAIN Management Board". Zwingenberg. 2016-09-23
Merck KGaA. (9/23/16). "Press Release: Merck Appoints Isabel De Paoli as Chief Strategy Officer". Darmstadt. 2016-09-23
Ergomed plc. (9/22/16). "Press Release: Ergomed’s Full Service Contract Win Validates Strategic Rationale of Recent Acquisitions". London. 2016-09-22
Sygnis AG. (9/22/16). "Press Release: Sygnis AG Enters into Collaboration Agreement with ECACC for Licensing and Distribution of Caco-2 Cell Line". Madrid & Heidelberg. 2016-09-22
Pieris Pharmaceuticals, Inc.. (9/22/16). "Press Release: Pieris Pharmaceuticals Appoints Christopher Kiritsy to Its Board of Directors". Boston, MA. 2016-09-22
Selexis S.A.. (9/22/16). "Press Release: Selexis SA and IAVI Expand Collaboration to Advance Multiple HIV Vaccine Candidates Toward Clinical Testing". Geneva. 2016-09-22
Evotec AG. (9/22/16). "Press Release: Evotec Enters into a Research Collaboration with Inserm in Oncology". Hamburg. 2016-09-22
iOmx Therapeutics AG. (9/22/16). "Press Release: iOmx Therapeutics Raises EUR 40 Million in Series A Round". Martinsried. 2016-09-22
Evotec AG. (9/21/16). "Press Release: Evotec and Bayer Partner to Develop New Treatments to Fight Kidney Diseases". Hamburg. 2016-09-21
4SC AG. (9/21/16). "Press Release: Dr Jason Loveridge Appointed New CEO of 4SC". Planegg-Martinsried. 2016-09-21
Artios Pharma Ltd.. (9/21/16). "Press Release: Artios Pharma Company Launch and Fundraising of $33.2 Million to Focus on Novel DNA Damage Response (DDR) Cancer Therapies". Cambridge. 2016-09-21
MorphoSys AG. (9/19/16). "Press Release: Lanthio Pharma Expands Management Team". 2016-09-19
Wilex AG. (9/19/16). "Press Release: Wilex AG – Subsidiary Heidelberg Pharma Signs Option Agreement with Max Delbrück Center". Munich. 2016-09-19
Sanofi S.A.. (9/16/16). "Press Release: Treatment Effects Maintained Over Six Years in Patients with Relapsing Remitting Multiple Sclerosis who Received Sanofi Genzyme’s Lemtrada (alemtuzumab) in Clinical Trials". Paris. 2016-09-16
Analytik Jena AG. (9/16/16). "Press Release: Ulrich Krauss to Succeed Analytik Jena Founder Klaus Berka as CEO on October 1, 2016". Jena. 2016-09-16
Rentschler Biotechnologie GmbH. (9/16/16). "Press Release: Rentschler Doubles Manufacturing Capacity to Address Growing Demand for Biopharmaceuticals". Laupheim. 2016-09-16
Boehringer Ingelheim. (9/16/16). "Press Release: Glyxambi (empagliflozin/linagliptin) Approval Recommended by CHMP for Adults with Type 2 Diabetes in the European Union". Ingelheim & Indianapolis, IN. 2016-09-16
Novozymes A/S. (9/15/16). "Press Release: Novozymes Acquires Organobalance GmbH to Strengthen Position in Microbial Solutions". 2016-09-15
Bayer AG. (9/14/16). "Press Release: Bayer and Monsanto to Create a Global Leader in Agriculture". Leverkusen & St. Louis, MI. 2016-09-14
Merck KGaA. (9/13/16). "Press Release: Merck Lab Earns ISO Accreditation for Quality Control of Culture Media". Darmstadt. 2016-09-13
Sanofi S.A.. (9/13/16). "Press Release: Sanofi’s Fixed-Ratio Combination Helps More Patients Reach Mealtime Blood Sugar Target than Insulin Glargine Alone". Paris. 2016-09-13
Merck KGaA. (9/13/16). "Press Release: Merck’s Consumer Health Business Presents New Purpose to Help Prepare Society for 100 Healthy Years". 2016-09-13
AC Immune S.A.. (9/13/16). "Press Release: AC Immune Commences Proposed Initial Public Offering of Common Shares". Lausanne. 2016-09-13
Mologen AG. (9/12/16). "Press Release: Mologen Presents First Anti-tumor Data of the Product Candidate and TLR9 Agonist EnanDIM in a Murine Tumor Model". Berlin. 2016-09-12
Merck KGaA. (9/12/16). "Press Release: Merck Presents New Data on the Safety and Durable Efficacy of Cladribine Tablets and Advantages of Early Treatment with Rebif at the 2016 ECTRIMS Congress". Darmstadt. 2016-09-12
MorphoSys AG. (9/12/16). "Press Release: MorphoSys Appoints Four R&D Experts to Its Newly Formed Scientific Advisory Board". 2016-09-12
Analytik Jena AG. (9/12/16). "Press Release: Joint Appearance at ILMAC. Endress+Hauser and Analytik Jena Present Themselves at Leading Swiss Industry Trade Fair". Basel & Jena. 2016-09-12
Qiagen N.V.. (9/10/16). "Press Release: Qiagen Comments on Preliminary Injunction and Confirms Intention to Defend Its U.S. Intellectual Property Position". Venlo & Hilden. 2016-09-10
Bayer AG. (9/8/16). "Press Release: Bayer and Forschungszentrum Juelich Agree on Research Collaboration". Monheim. 2016-09-08
Postnova Analytics GmbH. (9/8/16). "Press Release: Postnova Analytics übernimmt Geschäftsbereich Chromatographie-Zubehör der MedChrom GmbH". Landsberg am Lech. 2016-09-08
Vivasure Medical Ltd.. (9/8/16). "Press Release: Vivasure Medical Announces €16.2M ($18.3M) in Financing to Advance Commercialization of Closure Device in European Union and United States". Galway. 2016-09-08
Merck KGaA. (9/8/16). "Press Release: Merck Launches New Gene Editing Technology to Engineer Virus Resistant CHO Cell Lines". Darmstadt. 2016-09-08
Curetis N.V.. (9/7/16). "Press Release: Curetis Acquires Patents and Rights to Genetic Antibiotic Resistance and Susceptibility (GEAR) Database and Know-How from Siemens". Amsterdam & Holzgerlingen. 2016-09-07
Evonik Industries AG. (9/7/16). "Press Release: Venture Capital. Evonik Invests in Irish Medical Device Company Vivasure Medical". Essen. 2016-09-07
AGC Asahi Glass. (9/6/16). "Press Release: AGC Acquires a Leading German Biopharmaceutical CMO". Tokyo. 2016-09-06
Rigontec GmbH. (9/6/16). "Press Release: Rigontec Raises Additional €15M in Extended Series A to Advance Novel RIG-I Targeted Immuno-Oncology Therapeutics". Bonn, Munich & Cambridge, MA. 2016-09-06
Bayer AG. (9/6/16). "Press Release: Negotiations Regarding Monsanto Acquisition Advance". Leverkusen. 2016-09-06
BioMed X GmbH. (9/6/16). "Press Release: BioMed X Announces the Start of New Research Team on Oral Biofilm Disruption through Continued Collaboration with Johnson & Johnson Innovation". Heidelberg. 2016-09-06
AMSilk GmbH. (9/6/16). "Press Release: AMSilk Expands Distribution Network in Asia". Planegg. 2016-09-06
Curetis N.V.. (9/6/16). "Press Release: Curetis to Launch Next Generation CE-IVD Unyvero Implant and Tissue Infection Application Cartridge". Amsterdam & Holzgerlingen. 2016-09-06
Sanofi S.A.. (9/6/16). "Press Release: Sanofi Successfully Prices EUR 3 Billion Bond Issue". Paris. 2016-09-06
MorphoSys AG. (9/6/16). "Press Release: MorphoSys Initiates Phase 2/3 Trial of CD19 Antibody MOR208 plus Bendamustine in Patients with Relapsed or Refractory DLBCL". 2016-09-06
Celonic AG. (9/5/16). "Press Release: Celonic and IBI-Lorenzini Announce a Strategic Collaboration on CHOvolution, an Innovative Integrated Cell Line Development Platform". Basel & Aprilia. 2016-09-05
Erytech Pharma. (9/5/16). "Press Release: Erytech Appoints Allene M. Diaz to Its Board of Directors". Lyon. 2016-09-05
RHAPSODY Project (IMI). (9/5/16). "Press Release: Launch of RHAPSODY. An Innovative Medicines Initiative Project for Precision Therapy and Prevention of Diabetes". Frankfurt, Lausanne, Suresnes & Lund. 2016-09-05
Galenica Holding AG. (9/2/16). "Press Release: Galenica Completes Acquisition of Relypsa". 2016-09-02
Vaximm AG. (9/1/16). "Press Release: Vaximm Appoints Dr. Matthias Schroff as Chief Executive Officer". Basel & Mannheim. 2016-09-01
Oxford Immunotec Global plc. (9/1/16). "Press Release: Oxford Immunotec Announces Favorable Recommendation by the Magistrate Judge in Patent Infringement Litigation". Oxford & Marlborough, MA. 2016-09-01
Sartorius AG. (9/1/16). "Press Release: Sartorius Stedim Biotech Presents the First Fully Integrated Upstream Platform". Göttingen & Aubagne. 2016-09-01
Horizon Discovery Group plc. (9/1/16). "Press Release: Horizon Discovery Group and Ventana Medical Systems Sign Co-development Agreement for Reference Standards". Cambridge. 2016-09-01
Phagenesis Ltd.. (9/1/16). "Press Release: The Staged Acquisition of Phagenesis by Nestlé Health Science Will Benefit Patients with Dysphagia". Manchester. 2016-09-01
Boehringer Ingelheim. (9/1/16). "Press Release: Amgen Obtains Global Development and Commercial Rights from Boehringer Ingelheim for Investigational BiTE Immuno-oncology Drug for Multiple Myeloma". Thousand Oaks, CA & Ingelheim. 2016-09-01
Gardner Denver, Inc.. (9/1/2016). "Press Release: Gardner Denver Medical Acquires the ILS GmbH and Zinsser Analytic GmbH". Wayne, PA & New York, NY. 2016-09-01
Tecan Group Ltd.. (8/31/16). "Press Release: Tecan to Acquire SPEware Corporation, a Leading Provider for Mass Spectrometry Sample Preparation Solutions". Männedorf. 2016-08-31
Debiopharm S.A.. (8/30/16). "Press Release: Debiopharm Invests Double Digit Millions in the Canadian Startup GenePOC, Specialized in the Development of Rapid Diagnostic Tests". Québec & Lausanne. 2016-08-30
Santhera Pharmaceuticals Holding AG. (8/30/16). "Press Release: Santhera Receives FDA Grant in Support of Its Ongoing Phase I Trial with Omigapil in Congenital Muscular Dystrophy". Liestal. 2016-08-30
Boehringer Ingelheim. (8/29/16). "Press Release: Saniona and Boehringer Ingelheim Sign Collaboration Agreement in Schizophrenia". Ingelheim. 2016-08-29
BRAIN AG. (8/29/16). "Press Release: BRAIN, AnalytiCon and Roquette Sign a Strategic Partnership for the Development of Next Generation Natural Sweetening Solutions". Zwingenberg & Lestrem. 2016-08-29
Boehringer Ingelheim. (8/29/16). "Press Release: Latest Data on Dabigatran Etexilate Safety and Effectiveness Profile Show Low Rates of Bleeding and Stroke in NVAF Patients in Routine Clinical Care". Ingelheim. 2016-08-29
Denali Therapeutics Inc.. (8/25/16). "Press Release: Denali Therapeutics Announces First Clinical Trial Application, Key Collaborations and $130m Series B". South San Francisco, CA. 2016-08-25
F-Star Biotechnology Ltd.. (8/25/16). "Press Release: F-Star Announces Collaborative Agreement with Denali Therapeutics for the Development of a Multispecific Antibody Platform to Deliver Therapeutics across the Blood-Brain Barrier". Cambridge & South Sa 2016-08-25
AB Sciex (d/b/a Sciex). (8/25/16). "Press Release: Sciex to Introduce Benchtop High Resolution Mass Spec for Forensic Toxicology Analysis at TIAFT 2016 Meeting in Brisbane, Australia, Aug 28 – Sep 1, 2016". Singapore. 2016-08-25
Earlybird VC Management GmbH & Co KG. (8/24/16). "Press Release: First Closing of the Earlybird Health Tech Fund". Berlin. 2016-08-24
AiCuris Anti-infective Cures GmbH. (8/23/16). "Press Release: AiCuris Topical Pritelivir, a Highly Active Inhibitor for the Treatment of Herpes Simplex Virus, Achieves Primary Endpoint in Clinical Phase I Study". Wuppertal. 2016-08-23
Ayoxxa Biosystems GmbH. (8/22/16). "Press Release: Ayoxxa and Märzhäuser Introduce a Benchtop Device for Protein Multiplex Analysis. Ayoxxa Reader AR01 is ready for the market". Cologne. 2016-08-22
Bruker Corporation. (8/22/16). "Press Release: Bruker Accelerates Extreme Resolution Isotope Fine Structure (IFS) Mass Spectrometry with Launch of New solariX 2XR FTMS System". Toronto, ON. 2016-08-22
Bruker Corporation. (8/22/16). "Press Release: Bruker Introduces MetaboScape 2.0 Solution for Metabolomics". Toronto, ON. 2016-08-22
Bayer AG. (8/19/16). "Press Release: Bayer and CRISPR Therapeutics Joint Venture, Named Casebia Therapeutics, Establishes Operations in Cambridge, MA". Leverkusen & Basel. 2016-08-19
Altona Diagnostics GmbH. (8/19/16). "Press Release: Altona Diagnostics Test for Zika Virus Accepted by WHO". 2016-08-19
Curetis N.V.. (8/19/16). "Press Release: Curetis Reports Financial Results for the First Six Months of 2016". Amsterdam & Holzgerlingen. 2016-08-19
Evolva Holding S.A.. (8/18/16). "Press Release: Evolva Publishes Financial Results for the First Half of 2016 and Provides Business Update". 2016-08-18
Theraclion S.A.. (8/18/16). "Press Release: Strong Interest of Investors in Theraclion – Capital increase Completed @ 100%. Total Amount Raised of €9,7M [Not for UK] 1,7 new shares issued at €5.98 per share". Malakoff. 2016-08-18
Evolva Holding S.A.. (8/17/16). "Press Release: Evolva Enters Partnership on Active Pharmaceutical Ingredients. Partner to Fully Fund Development of New Production Routes for a Family of APIs". 2016-08-17
Eppendorf AG. (8/16/16). "Press Release: Eppendorf Continues on Course for Success. Group Sales in First Half-year: €305.5 million (Sales Growth of 5.5%)". Hamburg. 2016-08-16
Eppendorf AG. (8/16/16). "Press Release: »Form follows function«. Safe and Contact-free Pipetting with epT.I.P.S. 5 mL L Tips". Hamburg. 2016-08-16
Tecan Group Ltd.. (8/16/16). "Press Release: Tecan Again Posts Double-digit Sales Growth in the First Half of 2016". Männedorf. 2016-08-16
Qiagen N.V.. (8/14/16). "Press Release: Qiagen Announces Plans to Return approximately $250 Million to Shareholders via Synthetic Share Repurchase Proposal". Venlo. 2016-08-14
4SC AG. (8/11/16). "Press Release: 4SC Provides Operational and Financial Update for Q2 and 6M 2016". Planegg-Martinsried. 2016-08-11
Biotest AG. (8/11/16). "Press Release: Biotest Increases EBIT Significantly. Strong EBIT Increase to EUR 18.2 million vs. EUR 2.3 million – Increase of Revenue by 6.4% to EUR 306 million ". Dreieich. 2016-08-11
Thermo Fisher Scientific Inc.. (8/11/16). "Press Release: Thermo Fisher Scientific Partners with Hamilton Bonaduz AG to Accelerate Automation Platforms Access for Forensic Customers". South San Francisco, CA & Bonaduz. 2016-08-11
Evolva Holding S.A.. (8/10/16). "Press Release: Evolva’s Collaboration with US Navy to Focus on Resveratrol-based Composites". 2016-08-10
Affimed N.V.. (8/10/16). "Press Release: Affimed Reports Financial Results for Second Quarter 2016 and Provides Corporate Update". Heidelberg. 2016-08-10
Polyphor Ltd.. (8/10/16). "Press Release: Polyphor and Gilead Establish R&D Macrocycle Drug Discovery Collaboration". Allschwil. 2016-08-10
Pieris Pharmaceuticals, Inc.. (8/10/16). "Press Release: Pieris Pharmaceuticals Reports Financial Results and Provides Corporate Update for the Second Quarter Ended June 30, 2016". Boston, MA. 2016-08-10
Epigenomics AG. (8/10/16). "Press Release: Epigenomics AG Confidentially Submits Draft Registration Statement for Potential U.S. Public Offering of ADSs". Berlin & Germantown, MD. 2016-08-10
Epigenomics AG. (8/10/16). "Press Release: Epigenomics AG Announces 2016 Second Quarter and Six Months Financial Results and Reports on Operational Highlights". Berlin & Germantown, MD. 2016-08-10
Evotec AG. (8/10/16). "Press Release: Evotec AG Reports Results of First Half of 2016". Hamburg. 2016-08-10
Medigene AG. (8/5/16). "Press Release: Medigene Reports Results of First Six Months 2016". Martinsried. 2016-08-05
Teva Pharmaceutical Industries Ltd.. (8/5/16). "Press Release: Teva Announces Launch of Generic Gleevec Tablets in the United States". Jerusalem. 2016-08-05
Altona Diagnostics GmbH. (8/5/16). "Press Release: Altona Diagnostics’ RealStar Zika Virus RT-PCR Kit 1.0 Receives Emergency Use Authorization for Korea". 2016-08-05
Evotec AG. (8/4/16). "Press Release: Evotec Achieves Clinical Development Milestone as Part of Its Multi-target Alliance with Bayer in Endometriosis". Hamburg. 2016-08-04
Evolva Holding S.A.. (8/4/16). "Press Release: Evolva Establishes Sales Office in Singapore". 2016-08-04
High-Tech Gründerfonds Management GmbH. (8/4/16). "Press Release: Akvola Technologies Secures Series A Financing Round". 2016-08-04
Merck KGaA. (8/4/16). "Press Release: Merck Lifts Forecast Following Good Second Quarter". Darmstadt. 2016-08-04
BRAIN AG. (8/3/16). "Press Release: BRAIN Granted Key Patent in the United States". Zwingenberg. 2016-08-03
Merck KGaA. (8/3/16). "Press Release: Merck Expands Portfolio of Certified Reference Materials for Applied Diagnostics and Testing". Darmstadt. 2016-08-03
Inovio Pharmaceuticals, Inc.. (8/3/16). "Press Release: Inovio Will Independently Develop Hepatitis B Immunotherapy". Plymouth Meeting, PA. 2016-08-03
Biotest AG. (8/3/16). "Press Release: Announcement according to Article 17 European Market Abuse Regulation (MAR). Altered Tax Assessments for 2005 – 2008". Dreieich. 2016-08-03
1 2 3 ... 103 104 105  next pagenext page


Picture [LSF] – The Business Web Portal 600x80px

To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to and simply fill the subject line with the word »LSG newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture [LSE] – The Business Web Portal 600x80px

» top


Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Mologen AG Investing in Power of Immunotherapy Middle 120x180px Picture EuropaBio European Biotech Week 2016 September 120x180px Picture EBD Group BIO Europe 2016 BEU Cologne November 120x180px Picture [LSE] – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px